63 related articles for article (PubMed ID: 21518523)
1. [Association of lymphoid malignancy incidence with EB Virus and IL-10 gene polymorphism].
Wang C; Pan L; Zhu P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):528-31. PubMed ID: 21518523
[TBL] [Abstract][Full Text] [Related]
2. Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10.
Benjamin D; Knobloch TJ; Dayton MA
Blood; 1992 Sep; 80(5):1289-98. PubMed ID: 1325212
[TBL] [Abstract][Full Text] [Related]
3. The AT-rich region between -54 to -66 is important for the promoter activity of interleukin-10 in Epstein-Barr virus positive Burkitt's lymphoma cells.
Kube D; Laser H; von Knethen A; Tesch H
Genes Immun; 1999 Nov; 1(2):105-14. PubMed ID: 11196656
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program.
De Leo A; Arena G; Stecca C; Raciti M; Mattia E
Mol Cancer Res; 2011 Oct; 9(10):1346-55. PubMed ID: 21856773
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus and Burkitt's lymphoma.
Magrath I; Jain V; Bhatia K
Semin Cancer Biol; 1992 Oct; 3(5):285-95. PubMed ID: 1335792
[TBL] [Abstract][Full Text] [Related]
6. The role of Epstein Barr virus (EBV) in Burkitt's lymphomas.
zur Hausen H
Jpn J Cancer Res; 1998 Mar; 89(3):inside cover. PubMed ID: 9600115
[No Abstract] [Full Text] [Related]
7. Epstein-Barr virus-encoded poly(A)(-) RNA supports Burkitt's lymphoma growth through interleukin-10 induction.
Kitagawa N; Goto M; Kurozumi K; Maruo S; Fukayama M; Naoe T; Yasukawa M; Hino K; Suzuki T; Todo S; Takada K
EMBO J; 2000 Dec; 19(24):6742-50. PubMed ID: 11118209
[TBL] [Abstract][Full Text] [Related]
8. Lymphoma and Epstein-Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trial.
de Lastours V; LeGoff J; Brière J; Agbalika F; Boulet T; Lévy Y; Simon F; Aboulker JP; Molina JM
HIV Med; 2014 Jan; 15(1):23-9. PubMed ID: 24007426
[TBL] [Abstract][Full Text] [Related]
9. Indole-3-carbinol induces cMYC and IAP-family downmodulation and promotes apoptosis of Epstein-Barr virus (EBV)-positive but not of EBV-negative Burkitt's lymphoma cell lines.
Perez-Chacon G; de Los Rios C; Zapata JM
Pharmacol Res; 2014 Nov; 89():46-56. PubMed ID: 25180456
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus: 40 years on.
Young LS; Rickinson AB
Nat Rev Cancer; 2004 Oct; 4(10):757-68. PubMed ID: 15510157
[TBL] [Abstract][Full Text] [Related]
11. Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines.
Kube D; Platzer C; von Knethen A; Straub H; Bohlen H; Hafner M; Tesch H
Cytokine; 1995 Jan; 7(1):1-7. PubMed ID: 7749063
[TBL] [Abstract][Full Text] [Related]
12. Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line.
Szekely L; Chen F; Teramoto N; Ehlin-Henriksson B; Pokrovskaja K; Szeles A; Manneborg-Sandlund A; Löwbeer M; Lennette ET; Klein G
J Gen Virol; 1998 Jun; 79 ( Pt 6)():1445-52. PubMed ID: 9634087
[TBL] [Abstract][Full Text] [Related]
13. [Epstein-Barr Virus LMP1 oncogene variants in cell lines of different origin].
Yakovleva LS; Senyuta NB; Goncharova EV; Scherback LN; Smirnova RV; Pavlish OA; Gurtsevitch VE
Mol Biol (Mosk); 2015; 49(5):800-10. PubMed ID: 26510598
[TBL] [Abstract][Full Text] [Related]
14. Human B cell interleukin 10.
Benjamin D; Park CD; Sharma V
Leuk Lymphoma; 1994 Jan; 12(3-4):205-10. PubMed ID: 8167552
[TBL] [Abstract][Full Text] [Related]
15. The LCR of EBV makes Burkitt's lymphoma endemic.
Niller HH; Salamon D; Banati F; Schwarzmann F; Wolf H; Minarovits J
Trends Microbiol; 2004 Nov; 12(11):495-9. PubMed ID: 15488390
[TBL] [Abstract][Full Text] [Related]
16. The role of EBERs in oncogenesis.
Takada K; Nanbo A
Semin Cancer Biol; 2001 Dec; 11(6):461-7. PubMed ID: 11669608
[TBL] [Abstract][Full Text] [Related]
17. Telomere size and telomerase activity in Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cell lines.
Mochida A; Gotoh E; Senpuku H; Harada S; Kitamura R; Takahashi T; Yanagi K
Arch Virol; 2005 Oct; 150(10):2139-50. PubMed ID: 15986178
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of Epstein-Barr virus-encoded latent membrane protein by human herpesvirus 6 superinfection of EBV-carrying Burkitt lymphoma cells.
Cuomo L; Trivedi P; de Grazia U; Calogero A; D'Onofrio M; Yang W; Frati L; Faggioni A; Rymo L; Ragona G
J Med Virol; 1998 Jul; 55(3):219-26. PubMed ID: 9624610
[TBL] [Abstract][Full Text] [Related]
19. Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristics.
Magrath IT; Pizzo PA; Whang-Peng J; Douglass EC; Alabaster O; Gerber P; Freeman CB; Novikovs L
J Natl Cancer Inst; 1980 Mar; 64(3):465-76. PubMed ID: 6243721
[TBL] [Abstract][Full Text] [Related]
20. Efficient EBV superinfection of group I Burkitt's lymphoma cells distinguishes requirements for expression of the Cp viral promoter and can activate the EBV productive cycle.
Evans TJ; Jacquemin MG; Farrell PJ
Virology; 1995 Feb; 206(2):866-77. PubMed ID: 7856099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
